Pair Name | Aloe emodin, Gefitinib | ||
Phytochemical Name | Aloe emodin (PubChem CID: 10207 ) | ||
Anticancer drug Name | Gefitinib (PubChem CID: 123631 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Aloe emodin, Gefitinib | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Inhibition-->Epithelial-mesenchymal transition | |||
Gene Regulation | Down-regulation | Expression | AKT1 | hsa207 |
Down-regulation | Expression | PIK3CA | hsa5290 | |
Down-regulation | Expression | SLC22A3 | hsa6581 | |
In Vitro Model | PC-9 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_B260 |
PC-9-GR-high | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_S706 | |
In Vivo Model | After acclimated for one week, subcutaneous inoculation of 1×10⁷ PC9-GR cells was executed into the right flank of the animals (n = 4 in each group) to develop xenograft models. | |||
Result | AE could enhance the gefitinib sensitivity of PC9-GR cells and reverse EMT by blocking PI3K/Akt/TWIS1 signal pathway. |
No. | Title | Href |
---|---|---|
1 | Sensitization of Non-Small Cell Lung Cancer Cells to Gefitinib and Reversal of Epithelial-Mesenchymal Transition by Aloe-Emodin Via PI3K/Akt/TWIS1 Signal Blockage. Front Oncol. 2022 May 23;12:908031. doi: 10.3389/fonc.2022.908031. | Click |